Photo-Oxidation Mechanisms in Liquid Pharmaceutical Formulations: The Overlooked Role of Singlet Oxygen Presented as a Case Study
- PMID: 36131113
- DOI: 10.1007/s11095-022-03374-z
Photo-Oxidation Mechanisms in Liquid Pharmaceutical Formulations: The Overlooked Role of Singlet Oxygen Presented as a Case Study
Abstract
Purpose: Oxidation is one of the most common degradation pathways for active pharmaceutical ingredients (APIs) in pharmaceutical formulations, mostly involving 1-electron processes via peroxy radicals and 2-electron processes by peroxides. In liquid pharmaceutical formulations, several factors can impact oxidative instabilities including pH, excipient impurities, headspace oxygen, and the potential for photo-oxidation. Photo-oxidation can be particularly challenging to characterize given the number of oxidative mechanisms which can occur. This was observed during formulation development of a new chemical entity, MK-1454, where a degradation peak was observed during photostability studies which was not previously observed during peroxide and peroxyradical forced stress studies.
Methods: To gain a fundamental understanding of reactive oxygen species generation and its role in degradation of MK-1454, experiments were performed with materials which either generate or measure reactive oxygen species including organic hydroperoxides, singlet oxygen, and superoxide to fundamentally understand a photodegradation mechanism which was observed in the original formulation. LC-MS experiments further elucidated the structure and mechanism of this observed degradation pathway.
Results: A clear relationship between the decrease in dissolved oxygen after light exposure and the loss of MK-1454 was established. The data indicate that singlet oxygen is the most likely contributor of a particular photodegradation product. The singlet oxygen was generated by the inactive ingredients in the formulation, and LC-MS confirm this as the most likely pathway.
Conclusion: This work highlights the importance of understanding photochemical degradation of APIs in solution formulations and provides approaches which can better elucidate those mechanisms and thereby control strategies.
Keywords: excipients; histidine; liquid formulation; oxidative degradation; photodegradation; reactive oxygen species.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Akers MJ. Excipient–drug interactions in parenteral formulations. J Pharm Sci. 2002;91(11):2283–300. - DOI
-
- Stroop SD, Conca DM, Lundgard RP, Renz ME, Peabody LM, Leigh SD. Photosensitizers form in histidine buffer and mediate the photodegradation of a monoclonal antibody. J Pharm Sci. 2011;100(12):5142–55. - DOI
-
- Wang C, Yamniuk A, Dai J, Chen S, Stetsko P, Ditto N, et al. Investigation of a degradant in a biologics formulation buffer containing L-histidine. Pharm Res. 2015;32(8):2625–35. - PubMed
-
- Hovorka SW, Schöneich C. Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. J Pharm Sci. 2001;90(3):253–69. - DOI
-
- Janga KY, King T, Ji N, Sarabu S, Shadambikar G, Sawant S, et al. Photostability issues in pharmaceutical dosage forms and photostabilization. AAPS PharmSciTech. 2018;19(1):48–59. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources